Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	aminobutyraldehyde dehydrogenase (NAD+) activity	ALDH1A1 ALDH9A1	5.31e-05	2	146	2	GO:0019145
GeneOntologyMolecularFunction	aminoacyltransferase activity	FBXO40 RNF169 HDAC4 PELI3 BIRC2 HUWE1 TRIM23 TGM1 GGTLC1 PRPF19 HERC2 HERC1 TRIM44	1.48e-04	532	146	13	GO:0016755
GeneOntologyBiologicalProcess	mesenchyme migration	ACTA1 ACTA2 ACTC1 FOXF1	1.17e-08	5	145	4	GO:0090131
GeneOntologyBiologicalProcess	myotube differentiation	NPHS1 HDAC4 ACTA1 ADAM12 EHD2 SORT1 DYRK1B MYOCD	2.13e-05	164	145	8	GO:0014902
Domain	Actin/actin-like_CS	ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2	2.01e-07	18	144	5	IPR020902
Domain	ACTINS_1	ACTBL2 ACTA1 ACTA2 ACTC1	2.32e-07	8	144	4	PS00406
Domain	ACTINS_ACT_LIKE	ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2	2.71e-07	19	144	5	PS01132
Domain	Actin	ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2	3.67e-06	31	144	5	IPR004000
Domain	Actin	ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2	3.67e-06	31	144	5	PF00022
Domain	ACTIN	ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2	3.67e-06	31	144	5	SM00268
Domain	Actin_CS	ACTBL2 ACTA1 ACTA2 ACTC1	5.74e-06	16	144	4	IPR004001
Domain	ACTINS_2	ACTBL2 ACTA1 ACTA2 ACTC1	7.46e-06	17	144	4	PS00432
Domain	Cadherin_tail	PCDHGA11 PCDHGA7 PCDHGA6 PCDHGA1	1.84e-04	37	144	4	PF15974
Domain	Cadherin_CBD	PCDHGA11 PCDHGA7 PCDHGA6 PCDHGA1	1.84e-04	37	144	4	IPR031904
Domain	Cadherin_CS	PCDHGA11 PCDHGA7 PCDHGA6 PCDHGA1 FAT3 CDH23	2.00e-04	109	144	6	IPR020894
Domain	CADHERIN_1	PCDHGA11 PCDHGA7 PCDHGA6 PCDHGA1 FAT3 CDH23	2.43e-04	113	144	6	PS00232
Domain	Cadherin	PCDHGA11 PCDHGA7 PCDHGA6 PCDHGA1 FAT3 CDH23	2.43e-04	113	144	6	PF00028
Domain	CADHERIN_2	PCDHGA11 PCDHGA7 PCDHGA6 PCDHGA1 FAT3 CDH23	2.55e-04	114	144	6	PS50268
Domain	-	PCDHGA11 PCDHGA7 PCDHGA6 PCDHGA1 FAT3 CDH23	2.55e-04	114	144	6	2.60.40.60
Domain	CA	PCDHGA11 PCDHGA7 PCDHGA6 PCDHGA1 FAT3 CDH23	2.67e-04	115	144	6	SM00112
Domain	Cadherin-like	PCDHGA11 PCDHGA7 PCDHGA6 PCDHGA1 FAT3 CDH23	2.80e-04	116	144	6	IPR015919
Domain	Cadherin_C	PCDHGA11 PCDHGA7 PCDHGA6 PCDHGA1	3.02e-04	42	144	4	IPR032455
Domain	Cadherin_C_2	PCDHGA11 PCDHGA7 PCDHGA6 PCDHGA1	3.02e-04	42	144	4	PF16492
Domain	Cadherin	PCDHGA11 PCDHGA7 PCDHGA6 PCDHGA1 FAT3 CDH23	3.07e-04	118	144	6	IPR002126
Domain	Terpenoid_cyclase/PrenylTrfase	FNTB C4A C4B	3.36e-04	18	144	3	IPR008930
Domain	NUT	NUTM2G NUTM2F	5.81e-04	5	144	2	IPR024310
Domain	NUT_N	NUTM2G NUTM2F	5.81e-04	5	144	2	IPR024309
Domain	Anaphylatoxin_comp_syst	C4A C4B	5.81e-04	5	144	2	IPR018081
Domain	Anaphylatoxn_comp_syst_dom	C4A C4B	5.81e-04	5	144	2	IPR001840
Domain	EHD_N	EHD2 SRL	5.81e-04	5	144	2	IPR031692
Domain	NUT	NUTM2G NUTM2F	5.81e-04	5	144	2	PF12881
Domain	EHD_N	EHD2 SRL	5.81e-04	5	144	2	PF16880
Domain	PAK_BD	PAK1 PAK2	8.68e-04	6	144	2	IPR033923
Domain	HECT	HUWE1 HERC2 HERC1	1.15e-03	27	144	3	PF00632
Domain	HECTc	HUWE1 HERC2 HERC1	1.15e-03	27	144	3	SM00119
Domain	HECT_dom	HUWE1 HERC2 HERC1	1.15e-03	27	144	3	IPR000569
Domain	HECT	HUWE1 HERC2 HERC1	1.15e-03	27	144	3	PS50237
Domain	ANATO	C4A C4B	1.21e-03	7	144	2	SM00104
Domain	WASP_C	PAK1 PAK2	1.21e-03	7	144	2	IPR011026
Domain	ANAPHYLATOXIN_2	C4A C4B	1.21e-03	7	144	2	PS01178
Domain	ANAPHYLATOXIN_1	C4A C4B	1.21e-03	7	144	2	PS01177
Domain	ANATO	C4A C4B	1.21e-03	7	144	2	PF01821
Domain	Anaphylatoxin/fibulin	C4A C4B	1.21e-03	7	144	2	IPR000020
Domain	WD40_repeat	DCAF8L2 WDR47 WDHD1 STRN4 PRPF19 HERC2 HERC1 DYNC1I2	1.25e-03	272	144	8	IPR001680
Domain	WD_REPEATS_2	DCAF8L2 WDR47 WDHD1 STRN4 PRPF19 HERC2 HERC1 DYNC1I2	1.47e-03	279	144	8	PS50082
Domain	WD_REPEATS_REGION	DCAF8L2 WDR47 WDHD1 STRN4 PRPF19 HERC2 HERC1 DYNC1I2	1.47e-03	279	144	8	PS50294
Domain	Cadherin_2	PCDHGA11 PCDHGA7 PCDHGA6 PCDHGA1	1.59e-03	65	144	4	PF08266
Domain	Cadherin_N	PCDHGA11 PCDHGA7 PCDHGA6 PCDHGA1	1.59e-03	65	144	4	IPR013164
Domain	MacrogloblnA2_thiol-ester-bond	C4A C4B	1.60e-03	8	144	2	IPR019565
Domain	Thiol-ester_cl	C4A C4B	1.60e-03	8	144	2	PF10569
Domain	MacrogloblnA2_CS	C4A C4B	1.60e-03	8	144	2	IPR019742
Domain	A2M	C4A C4B	2.55e-03	10	144	2	PF00207
Domain	A2M_N_2	C4A C4B	2.55e-03	10	144	2	IPR011625
Domain	A2M_comp	C4A C4B	2.55e-03	10	144	2	IPR011626
Domain	A2M_recep	C4A C4B	2.55e-03	10	144	2	PF07677
Domain	A2M_comp	C4A C4B	2.55e-03	10	144	2	PF07678
Domain	A2M_N	C4A C4B	2.55e-03	10	144	2	PF01835
Domain	A2M_N	C4A C4B	2.55e-03	10	144	2	IPR002890
Domain	A-macroglobulin_rcpt-bd	C4A C4B	2.55e-03	10	144	2	IPR009048
Domain	ALPHA_2_MACROGLOBULIN	C4A C4B	2.55e-03	10	144	2	PS00477
Domain	A2M_N_2	C4A C4B	2.55e-03	10	144	2	PF07703
Domain	Macroglobln_a2	C4A C4B	2.55e-03	10	144	2	IPR001599
Domain	Kinase-like_dom	ATR MAP3K8 RPS6KB1 MINK1 FN3K DYRK1B PAK1 PAK2 PNCK LTK FOXF1	3.23e-03	542	144	11	IPR011009
Domain	-	PAK1 PAK2	3.70e-03	12	144	2	3.90.810.10
Domain	WD40	DCAF8L2 WDR47 WDHD1 STRN4 PRPF19 HERC1 DYNC1I2	4.00e-03	259	144	7	PF00400
Domain	-	DCAF8L2 WDR47 SORT1 WDHD1 STRN4 PRPF19 HERC1 DYNC1I2	4.35e-03	333	144	8	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	DCAF8L2 WDR47 SORT1 WDHD1 STRN4 PRPF19 HERC1 DYNC1I2	4.51e-03	335	144	8	IPR015943
Domain	WD40	DCAF8L2 WDR47 WDHD1 STRN4 PRPF19 HERC1 DYNC1I2	4.81e-03	268	144	7	SM00320
Domain	G_DYNAMIN_dom	EHD2 SRL	5.06e-03	14	144	2	IPR030381
Domain	G_DYNAMIN_2	EHD2 SRL	5.06e-03	14	144	2	PS51718
Domain	Dynamin_GTPase	EHD2 SRL	5.80e-03	15	144	2	IPR001401
Domain	Dynamin_SF	EHD2 SRL	5.80e-03	15	144	2	IPR022812
Domain	Dynamin_N	EHD2 SRL	5.80e-03	15	144	2	PF00350
Domain	WD_REPEATS_1	WDR47 WDHD1 STRN4 PRPF19 HERC2 HERC1 DYNC1I2	5.85e-03	278	144	7	PS00678
Domain	Ald_DH_CS_GLU	ALDH1A1 ALDH9A1	6.60e-03	16	144	2	IPR029510
Domain	PBD	PAK1 PAK2	6.60e-03	16	144	2	SM00285
Domain	C345C	C4A C4B	7.44e-03	17	144	2	SM00643
Domain	Ald_DH_CS_CYS	ALDH1A1 ALDH9A1	7.44e-03	17	144	2	IPR016160
Domain	PBD	PAK1 PAK2	7.44e-03	17	144	2	PF00786
Pathway	WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS	ACTA1 ACTA2 ACTC1 PAK1 PAK2	2.49e-05	47	105	5	M39829
Pubmed	siRNA and pharmacological inhibition of endocytic pathways to characterize the differential role of macropinocytosis and the actin cytoskeleton on cellular uptake of dextran and cationic cell penetrating peptides octaarginine (R8) and HIV-Tat.	ACTA1 ACTA2 ACTC1 PAK1	1.15e-08	7	150	4	22465675
Pubmed	Human immunodeficiency virus type 1 Tat regulates endothelial cell actin cytoskeletal dynamics through PAK1 activation and oxidant production.	ACTA1 ACTA2 ACTC1 PAK1	2.30e-08	8	150	4	14694110
Pubmed	Lentiviral Nef proteins utilize PAK2-mediated deregulation of cofilin as a general strategy to interfere with actin remodeling.	ACTA1 ACTA2 ACTC1 PAK2	2.30e-08	8	150	4	20147394
Pubmed	Reexamination of chromosomal loci of human muscle actin genes by fluorescence in situ hybridization.	ACTA1 ACTA2 ACTC1	7.86e-08	3	150	3	7780165
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	RNF169 OFD1 ACTBL2 MINK1 ACTA1 HUWE1 SORT1 FAM171A1 PPP5C PTPRZ1 FECH PRPF19 HERC2 HERC1 TNS1 CPSF3 SNTB2 PPP6R3 VAT1	1.46e-07	1049	150	19	27880917
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	HDAC4 CENPF RPS6KB1 MINK1 HUWE1 ADNP LDB2 WDR47 FAM171A1 NCAN STRN4 PAK1 UBA6 PAK2 TJAP1 HERC2 BSN TNS1	2.02e-07	963	150	18	28671696
Pubmed	Conditional mutagenesis of the murine serum response factor gene blocks cardiogenesis and the transcription of downstream gene targets.	ACTA1 ACTA2 ACTC1 MYOCD	9.70e-07	18	150	4	15929941
Pubmed	Heart-specific ablation of Prkar1a causes failure of heart development and myxomagenesis.	ACTA1 ACTA2 ACTC1 MYOCD	1.23e-06	19	150	4	18316483
Pubmed	Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein.	ACTA1 ACTA2 ACTC1	1.56e-06	6	150	3	9971772
Pubmed	Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin.	ACTA1 ACTA2 ACTC1	1.56e-06	6	150	3	10074138
Pubmed	Virus assembly and plasma membrane domains: which came first?	ACTA1 ACTA2 ACTC1	1.56e-06	6	150	3	22989508
Pubmed	HIV-1 protease cleaves actin during acute infection of human T-lymphocytes.	ACTA1 ACTA2 ACTC1	1.56e-06	6	150	3	1540415
Pubmed	HIV type 1 Gag and nucleocapsid proteins: cytoskeletal localization and effects on cell motility.	ACTA1 ACTA2 ACTC1	1.56e-06	6	150	3	11709093
Pubmed	Tagging the human immunodeficiency virus gag protein with green fluorescent protein. Minimal evidence for colocalisation with actin.	ACTA1 ACTA2 ACTC1	1.56e-06	6	150	3	10049817
Pubmed	Human immunodeficiency virus nucleocapsid protein polymorphisms modulate the infectivity of RNA packaging mutants.	ACTA1 ACTA2 ACTC1	1.56e-06	6	150	3	12009869
Pubmed	HIV-1 Tat protein variants: critical role for the cysteine region in synaptodendritic injury.	ACTA1 ACTA2 ACTC1	1.56e-06	6	150	3	23811015
Pubmed	Retroviral assembly and budding occur through an actin-driven mechanism.	ACTA1 ACTA2 ACTC1	1.56e-06	6	150	3	19883584
Pubmed	Dynamic imaging of cell-free and cell-associated viral capture in mature dendritic cells.	ACTA1 ACTA2 ACTC1	1.56e-06	6	150	3	21917091
Pubmed	HIV-1 Gag protein associates with F-actin present in microfilaments.	ACTA1 ACTA2 ACTC1	1.56e-06	6	150	3	8661406
Pubmed	A protein ballet around the viral genome orchestrated by HIV-1 reverse transcriptase leads to an architectural switch: from nucleocapsid-condensed RNA to Vpr-bridged DNA.	ACTA1 ACTA2 ACTC1	1.56e-06	6	150	3	23017337
Pubmed	Synaptodendritic recovery following HIV Tat exposure: neurorestoration by phytoestrogens.	ACTA1 ACTA2 ACTC1	1.56e-06	6	150	3	23875777
Pubmed	Establishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeleton.	ACTA1 ACTA2 ACTC1	1.56e-06	6	150	3	9841925
Pubmed	Myocardial Mycn is essential for mouse ventricular wall morphogenesis.	RPS6KB1 ACTA1 ACTA2 ACTC1	1.88e-06	21	150	4	23063798
Pubmed	The PDZ-adaptor protein syntenin-1 regulates HIV-1 entry.	ACTA1 ACTA2 ACTC1	2.72e-06	7	150	3	22535526
Pubmed	Selective targeting of ITK blocks multiple steps of HIV replication.	ACTA1 ACTA2 ACTC1	2.72e-06	7	150	3	18443296
Pubmed	The trinity of the cortical actin in the initiation of HIV-1 infection.	ACTA1 ACTA2 ACTC1	2.72e-06	7	150	3	22640593
Pubmed	HIV-1 replication from after cell entry to the nuclear periphery.	ACTA1 ACTA2 ACTC1	2.72e-06	7	150	3	17504171
Pubmed	Mice lacking factor VII develop normally but suffer fatal perinatal bleeding.	ACTA1 ACTA2 ACTC1	2.72e-06	7	150	3	9384381
Pubmed	A Novel Mouse Model for Cilia-Associated Cardiovascular Anomalies with a High Penetrance of Total Anomalous Pulmonary Venous Return.	ACTA1 ACTA2 ACTC1	2.72e-06	7	150	3	30289203
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	ESPN CENPF PCDHGA11 PCDHGA7 PCDHGA6 PCDHGA1 ACTBL2 ACTA1 ACTA2 NUCB1 SANBR ACTC1 SLC27A1 STRN4 PRPF19 GNAI3 ALDH1A1 BSN DYNC1I2 VAT1	4.23e-06	1442	150	20	35575683
Pubmed	Reduced versican cleavage due to Adamts9 haploinsufficiency is associated with cardiac and aortic anomalies.	ACTA1 ACTA2 ACTC1	4.33e-06	8	150	3	20096780
Pubmed	Interleukin 2-inducible T cell kinase (ITK) facilitates efficient egress of HIV-1 by coordinating Gag distribution and actin organization.	ACTA1 ACTA2 ACTC1	4.33e-06	8	150	3	23260110
Pubmed	Forkhead box F2 regulation of platelet-derived growth factor and myocardin/serum response factor signaling is essential for intestinal development.	ACTA2 MYOCD IHH FOXF1	5.40e-06	27	150	4	25631042
Pubmed	Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF.	ACTA1 ACTA2 ACTC1	6.48e-06	9	150	3	10556093
Pubmed	Modulation of cardiac growth and development by HOP, an unusual homeodomain protein.	ACTA1 ACTA2 ACTC1	6.48e-06	9	150	3	12297046
Pubmed	Cytoskeletal proteins inside human immunodeficiency virus type 1 virions.	ACTA1 ACTA2 ACTC1	6.48e-06	9	150	3	8892894
Pubmed	HIV envelope-CXCR4 signaling activates cofilin to overcome cortical actin restriction in resting CD4 T cells.	ACTA1 ACTA2 ACTC1	6.48e-06	9	150	3	18775311
Pubmed	Actin, troponin C, Alzheimer amyloid precursor protein and pro-interleukin 1 beta as substrates of the protease from human immunodeficiency virus.	ACTA1 ACTA2 ACTC1	9.23e-06	10	150	3	1907279
Pubmed	HLA-association of serum levels of natural antibodies.	HLA-DQA1 C4A C4B	9.23e-06	10	150	3	19167759
Pubmed	Altered versican cleavage in ADAMTS5 deficient mice; a novel etiology of myxomatous valve disease.	ACTA1 ACTA2 ACTC1	9.23e-06	10	150	3	21749862
Pubmed	Non-viral cellular substrates for human immunodeficiency virus type 1 protease.	ACTA1 ACTA2 ACTC1	9.23e-06	10	150	3	1991513
Pubmed	Gelsolin activity controls efficient early HIV-1 infection.	ACTA1 ACTA2 ACTC1	9.23e-06	10	150	3	23575248
Pubmed	NFκB1 is essential to prevent the development of multiorgan autoimmunity by limiting IL-6 production in follicular B cells.	MAP3K8 BCL6 C4A C4B	9.55e-06	31	150	4	27022143
Pubmed	The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse.	ACTA1 ACTA2 ACTC1 FOXF1	1.09e-05	32	150	4	23369715
Pubmed	CAP2 deficiency delays myofibril actin cytoskeleton differentiation and disturbs skeletal muscle architecture and function.	ACTA1 ACTA2 ACTC1	1.26e-05	11	150	3	30962377
Pubmed	N-terminal Slit2 inhibits HIV-1 replication by regulating the actin cytoskeleton.	ACTA1 ACTA2 ACTC1	1.26e-05	11	150	3	23294842
Pubmed	Loss-of-function variants in myocardin cause congenital megabladder in humans and mice.	ACTA2 ACTC1 MYOCD	1.26e-05	11	150	3	31513549
Pubmed	FRS2α-mediated FGF signals suppress premature differentiation of cardiac stem cells through regulating autophagy activity.	ACTA1 ACTA2 ACTC1	1.26e-05	11	150	3	22207710
Pubmed	Quantitative proteomic analysis of lentiviral vectors using 2-DE.	ACTA1 ACTA2 ACTC1	1.26e-05	11	150	3	19639585
Pubmed	Functional significance of isoform diversification in the protocadherin gamma gene cluster.	PCDHGA11 PCDHGA7 PCDHGA6 BSN	1.39e-05	34	150	4	22884324
Pubmed	SEMA6D regulates perinatal cardiomyocyte proliferation and maturation in mice.	ACTA1 ACTA2 ACTC1	1.68e-05	12	150	3	31042497
Pubmed	HIV-1 Nef impairs heterotrimeric G-protein signaling by targeting Gα(i2) for degradation through ubiquitination.	ACTA1 ACTA2 ACTC1	1.68e-05	12	150	3	23071112
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	FNTB ACTBL2 ACTA1 NUCB1 SHMT1 HUWE1 PPP5C WDHD1 UBXN7 STRN4 UBA6 PAK2 PRPF19 GNAI3 HERC1 ALDH9A1 DYNC1I2 PPP6R3 VAT1	1.74e-05	1455	150	19	22863883
Pubmed	The MYO6 interactome reveals adaptor complexes coordinating early endosome and cytoskeletal dynamics.	OFD1 FAM171A1 KANK1 STRN4 SNTB2 NOL8	1.79e-05	125	150	6	29467281
Pubmed	Copy number analysis of complement C4A, C4B and C4A silencing mutation by real-time quantitative polymerase chain reaction.	C4A C4B	1.85e-05	2	150	2	22737222
Pubmed	Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection.	C4A C4B	1.85e-05	2	150	2	16565498
Pubmed	Complete deficiencies of complement C4A and C4B including 2-bp insertion in codon 1213 are genetic risk factors of systemic lupus erythematosus in Thai populations.	C4A C4B	1.85e-05	2	150	2	15998580
Pubmed	High-throughput analysis of the C4 polymorphism by a combination of MLPA and isotype-specific ELISA's.	C4A C4B	1.85e-05	2	150	2	19062096
Pubmed	Activation of PAK1/2 during the shedding of platelet microvesicles.	PAK1 PAK2	1.85e-05	2	150	2	20523167
Pubmed	Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice.	C4A C4B	1.85e-05	2	150	2	19933335
Pubmed	Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4.	C4A C4B	1.85e-05	2	150	2	2459207
Pubmed	Antigen-induced B cell apoptosis is independent of complement C4.	C4A C4B	1.85e-05	2	150	2	17645767
Pubmed	Anti-DNA autoreactivity in C4-deficient mice.	C4A C4B	1.85e-05	2	150	2	12207352
Pubmed	Transcriptional regulation of ataxia-telangiectasia and Rad3-related protein by activated p21-activated kinase-1 protects keratinocytes in UV-B-induced premalignant skin lesions.	ATR PAK1	1.85e-05	2	150	2	28692051
Pubmed	Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients.	C4A C4B	1.85e-05	2	150	2	27758680
Pubmed	Genetically determined partial complement C4 deficiency states are not independent risk factors for SLE in UK and Spanish populations.	C4A C4B	1.85e-05	2	150	2	22387014
Pubmed	Investigation of changes in skeletal muscle alpha-actin expression in normal and pathological human and mouse hearts.	ACTA1 ACTC1	1.85e-05	2	150	2	20706863
Pubmed	Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner.	C4A C4B	1.85e-05	2	150	2	23749435
Pubmed	Copy number variations of complement component C4 are associated with Behçet's disease but not with ankylosing spondylitis associated with acute anterior uveitis.	C4A C4B	1.85e-05	2	150	2	23918728
Pubmed	Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein.	C4A C4B	1.85e-05	2	150	2	3037333
Pubmed	Evidence of a role for C4 in modulating interstitial inflammation in experimental glomerulonephritis.	C4A C4B	1.85e-05	2	150	2	11726230
Pubmed	Quantitative variations in the expression of the mouse serum antigen Ss and its sex-limited allotype Slp.	C4A C4B	1.85e-05	2	150	2	4216347
Pubmed	Sequence determination of the thiolester site of the fourth component of human complement.	C4A C4B	1.85e-05	2	150	2	6950384
Pubmed	Visual demonstration of the organization of the human complement C4 and 21-hydroxylase genes by high-resolution fluorescence in situ hybridization.	C4A C4B	1.85e-05	2	150	2	8660986
Pubmed	Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain.	C4A C4B	1.85e-05	2	150	2	8428773
Pubmed	Complement C4 deficiency--a plausible risk factor for non-tuberculous mycobacteria (NTM) infection in apparently immunocompetent patients.	C4A C4B	1.85e-05	2	150	2	24638111
Pubmed	Transcriptional repression of C4 complement by hepatitis C virus proteins.	C4A C4B	1.85e-05	2	150	2	21345967
Pubmed	Restriction fragment analysis of H-2 recombinant mouse strains with crossovers between E alpha and C4 genes.	C4A C4B	1.85e-05	2	150	2	2572548
Pubmed	The complement component C4 of mammals.	C4A C4B	1.85e-05	2	150	2	2302180
Pubmed	A 5' duplication of the alpha-cardiac actin gene in BALB/c mice is associated with abnormal levels of alpha-cardiac and alpha-skeletal actin mRNAs in adult cardiac tissue.	ACTA1 ACTC1	1.85e-05	2	150	2	3023046
Pubmed	Constitutive p21-activated kinase (PAK) activation in breast cancer cells as a result of mislocalization of PAK to focal adhesions.	PAK1 PAK2	1.85e-05	2	150	2	15047871
Pubmed	Gene CNVs and protein levels of complement C4A and C4B as novel biomarkers for partial disease remissions in new-onset type 1 diabetes patients.	C4A C4B	1.85e-05	2	150	2	22151770
Pubmed	C4d-positive chronic rejection: a frequent entity with a poor outcome.	C4A C4B	1.85e-05	2	150	2	18091514
Pubmed	Comprehensive approach to study complement C4 in systemic lupus erythematosus: Gene polymorphisms, protein levels and functional activity.	C4A C4B	1.85e-05	2	150	2	29080553
Pubmed	Genes for murine fourth complement component (C4) and sex-limited protein (Slp) identified by hybridization to C4- and Slp-specific cDNA.	C4A C4B	1.85e-05	2	150	2	6589636
Pubmed	C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production.	C4A C4B	1.85e-05	2	150	2	25339671
Pubmed	A study of association of the complement C4 mutations with systemic lupus erythematosus in the Malaysian population.	C4A C4B	1.85e-05	2	150	2	17728371
Pubmed	Structure and organization of the C4 genes.	C4A C4B	1.85e-05	2	150	2	6149580
Pubmed	Sequence heterogeneity of murine complementary DNA clones related to the C4 and C4-Slp isoforms of the fourth complement component.	C4A C4B	1.85e-05	2	150	2	6149581
Pubmed	The follicular dendritic cell restricted epitope, FDC-M2, is complement C4; localization of immune complexes in mouse tissues.	C4A C4B	1.85e-05	2	150	2	12115608
Pubmed	Biochemistry and biology of anaphylatoxins.	C4A C4B	1.85e-05	2	150	2	3542363
Pubmed	C4 from C4-high and C4-low mouse strains have identical sequences in the region corresponding to the isotype-specific segment of human C4.	C4A C4B	1.85e-05	2	150	2	2387317
Pubmed	Identification of the size and antigenic determinants of the human C4 gene by a polymerase chain-reaction-based amplification method.	C4A C4B	1.85e-05	2	150	2	16908004
Pubmed	Structural studies on the murine fourth component of complement (C4). IV. Demonstration that C4 and Slp are encoded by separate loci.	C4A C4B	1.85e-05	2	150	2	7365238
Pubmed	Interaction between the labile binding sites of the fourth (C4) and fifth (C5) human complement proteins and erythrocyte cell membranes.	C4A C4B	1.85e-05	2	150	2	7391573
Pubmed	Peritubular capillary C4d deposition in lupus nephritis different from antibody-mediated renal rejection.	C4A C4B	1.85e-05	2	150	2	17971360
Pubmed	Cooperative transcriptional repression by BCL6 and BACH2 in germinal center B-cell differentiation.	BACH2 BCL6	1.85e-05	2	150	2	24277074
Pubmed	Clinical features of patients with homozygous complement C4A or C4B deficiency.	C4A C4B	1.85e-05	2	150	2	29928053
Pubmed	Analysis of C4 and the C4 binding protein in the MRL/lpr mouse.	C4A C4B	1.85e-05	2	150	2	17971229
Pubmed	Transcripts of alpha-cardiac and alpha-skeletal actins are early markers for myogenesis in the mouse embryo.	ACTA1 ACTC1	1.85e-05	2	150	2	3075543
Interaction	ICE2 interactions	RNF169 OFD1 ACTA2 MUC5B SORT1 DYRK1B PIPSL	1.71e-06	77	150	7	int:ICE2
Interaction	FBXO40 interactions	FBXO40 ACTBL2 ACTA2 ACTC1	3.78e-06	15	150	4	int:FBXO40
Interaction	NAA80 interactions	BACH2 ACTBL2 ACTA2 ACTC1	3.78e-06	15	150	4	int:NAA80
Interaction	DYNLL2 interactions	ATMIN FBXO40 OFD1 ADNP FAM171A1 KANK1 STRN4 PAK1 BSN DYNC1I2	2.85e-05	263	150	10	int:DYNLL2
Interaction	TPTE2 interactions	OFD1 POLE KIAA0232 HUWE1 STRN4 HERC1	3.88e-05	84	150	6	int:TPTE2
Interaction	PFN3 interactions	ACTBL2 ACTA2 ACTC1	4.67e-05	10	150	3	int:PFN3
Interaction	ANGPTL8 interactions	ACTBL2 ACTA1 ACTA2	4.67e-05	10	150	3	int:ANGPTL8
Interaction	GPSM1 interactions	CHAMP1 TRIM23 USHBP1 GNAI3 PPP6R3	5.51e-05	55	150	5	int:GPSM1
Interaction	PHACTR2 interactions	ACTBL2 ACTA2 ACTC1 PRPF19	6.06e-05	29	150	4	int:PHACTR2
Interaction	IL17RE interactions	FAT3 ACTBL2 ACTA2	6.38e-05	11	150	3	int:IL17RE
Interaction	WASH8P interactions	ACTBL2 ACTA2 ACTC1	6.38e-05	11	150	3	int:WASH8P
Interaction	PPIAL4G interactions	PCDHGA11 FAT3 ACTBL2 EHD2	6.95e-05	30	150	4	int:PPIAL4G
Interaction	ZBBX interactions	POLE KIAA0232 FAT3 HERC1	7.93e-05	31	150	4	int:ZBBX
GeneFamily	Actins	ACTA1 ACTA2 ACTC1	2.13e-06	6	87	3	929
GeneFamily	Clustered protocadherins	PCDHGA11 PCDHGA7 PCDHGA6 PCDHGA1	2.55e-04	64	87	4	20
GeneFamily	WD repeat domain containing	DCAF8L2 WDR47 WDHD1 STRN4 PRPF19 HERC1 DYNC1I2	2.70e-04	262	87	7	362
GeneFamily	C3 and PZP like, alpha-2-macroglobulin domain containing	C4A C4B	8.06e-04	9	87	2	1234
Coexpression	GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_UP	PDE6H ATR KIAA0232 ACTA2 ACTC1 BIRC2 ADNP ADAM12 FAM171A1	1.98e-06	198	148	9	M5222
Coexpression	ENK_UV_RESPONSE_KERATINOCYTE_DN	ATR FNTB BIRC2 AGPS BCL6 MDH1 TRIM23 PTPRZ1 MCM3AP PAK1 TRIM44 SNTB2	1.95e-05	481	148	12	M3898
Coexpression	MCCLUNG_CREB1_TARGETS_DN	POU3F4 LDB2 C4A C4B PNCK	2.28e-05	60	148	5	MM654
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SYNM FAT3 ACTA2 ACTC1 POU3F4 MDH1 PNCK TNS1	1.74e-07	179	150	8	e860dca9b28ac5af61804bfd729cd39257cdb352
ToppCell	Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SYNM FAT3 ACTA1 ACTA2 SRL MYOCD PNCK TNS1	3.76e-07	198	150	8	1e1ea54f0c234f3b6d29064c4881d8a0c0949a75
ToppCell	Tracheal-10x3prime_v2-Stromal-Myofibroblastic\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	FBXO40 SYNM ACTA1 ACTA2 ACTC1 MYOCD PNCK TNS1	3.91e-07	199	150	8	534dcfe8b65ad92bb8d749d1c7036ad4807e09cd
ToppCell	PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ACTA2 ACTC1 GSDMC KANK1 PTPRZ1 MYOCD PNCK	1.21e-06	160	150	7	8624f101828efd32cdd38a65df8d94d690720a63
ToppCell	PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ACTA2 ACTC1 GSDMC KANK1 PTPRZ1 MYOCD PNCK	1.21e-06	160	150	7	9de3dd6b9d4b51314d60b3b01f4132bcfa2dfc18
ToppCell	15-Airway-Mesenchymal-Airway_Smooth_Muscle\|Airway / Age, Tissue, Lineage and Cell class	SYNM FAT3 ACTA2 ACTC1 C1QL1 MYOCD FOXF1	1.49e-06	165	150	7	531804467601e1ee1f771cffa21501f6d464ae10
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SYNM ACTA1 ACTA2 ACTC1 EHD2 GGTLC1 MYOCD	2.04e-06	173	150	7	ecbf7167d4bec685e3460d826318544946f5f5c2
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SYNM ACTA1 ACTA2 ACTC1 EHD2 GGTLC1 MYOCD	2.04e-06	173	150	7	b8dc978c52de64afba21ff6cb32e79f07167448e
ToppCell	facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE6H FAT3 ACTA2 SORT1 KANK1 MYOCD PNCK	2.12e-06	174	150	7	197686570cec6d96a92e77e6409325d3bfe6f991
ToppCell	facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE6H FAT3 ACTA2 SORT1 KANK1 MYOCD PNCK	2.12e-06	174	150	7	2eee7b5471672b439f95eba11494c2adf8cb7006
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_2\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	ACTA2 ACTC1 KANK1 C4A MYOCD PNCK FOXF1	2.96e-06	183	150	7	a1d4f25e13f5b9e92a9ca0a804a7bed5df8fb2fe
ToppCell	wk_08-11-Mesenchymal-Myofibro_&_SMC-ACTC+_SMC\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	SYNM ACTA2 ACTC1 MDH1 MYOCD PNCK FOXF1	3.07e-06	184	150	7	39168ca2bbf1369c9fe87c67f0aaff5e3cd03151
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SYNM ACTA2 ACTC1 MDH1 MYOCD PNCK ALDH1A1	3.41e-06	187	150	7	3912bbb610a4a84791e9bda92a2d57a52c31d29e
ToppCell	343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	SYNM PCDHGA7 LDB2 LTK NOS2 FOXF1 VAT1	3.54e-06	188	150	7	fe7143c36e4a883745862d3c3147cf751b440e46
ToppCell	343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)\|343B / Donor, Lineage, Cell class and subclass (all cells)	SYNM PCDHGA7 LDB2 LTK NOS2 FOXF1 VAT1	3.54e-06	188	150	7	cbf32b675a7cd0c808d5c9c22dfa7fa79fbe2437
ToppCell	IPF-Stromal-SMC\|IPF / Disease state, Lineage and Cell class	SYNM ACTA2 ACTC1 EHD2 SRL MYOCD C4B	3.54e-06	188	150	7	e98b24c0de41285f01f7ac194ff0a1b59fd5c333
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	CENPF FAT3 SHMT1 XRCC3 WDHD1 MYOCD FOXF1	3.79e-06	190	150	7	e83fa8b711aa79a1767818474f1c193b674b1c31
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SYNM FAT3 ACTA2 ACTC1 MDH1 MYOCD ALDH1A1	3.92e-06	191	150	7	de2cd94ee88a7754f86d39469e38374d668210c7
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SYNM ACTA2 ACTC1 MDH1 MYOCD PNCK ALDH1A1	4.35e-06	194	150	7	93bc72a933ccc6a760e5353f072afb606571c6fc
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SYNM ACTA2 ACTC1 MDH1 PNCK ALDH1A1 TNS1	4.35e-06	194	150	7	d2bafd31bb8333f66b6c714944bceb2f1aa11740
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SYNM ACTA2 ACTC1 EHD2 SRL MYOCD TNS1	4.81e-06	197	150	7	d16bb765afdc02406ffd7ce6a75bae72b66db66c
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-Pericytes\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SYNM ACTA2 ACTC1 EHD2 SRL MYOCD TNS1	4.81e-06	197	150	7	68c23c23b6924892f4c238cf2f5abc7927e04fbc
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SYNM ACTA2 ACTC1 SORT1 SRL MYOCD TNS1	4.97e-06	198	150	7	7dd874b09c81cc512ccc1e9b65f290a5f94d736e
ToppCell	390C-Fibroblasts-Fibroblast-K_(Pericytes)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	SYNM ACTA1 ACTA2 ACTC1 SORT1 MYOCD TNS1	5.31e-06	200	150	7	2bc7f462a551292de2501028164573935232f899
ToppCell	390C-Fibroblasts-Fibroblast-K_(Pericytes)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	SYNM ACTA1 ACTA2 ACTC1 SORT1 MYOCD TNS1	5.31e-06	200	150	7	8b80a65b69b36ed405214564b939452c90aa40d6
ToppCell	facs-Heart-LV-24m-Mesenchymal-atrial_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBXO40 CEBPE HLA-DQA1 MMP25 FECH FOXF1	9.11e-06	143	150	6	8f82b3c3331f20c6ded36dbfb9a48dbd9f099f93
ToppCell	facs-Heart-LV-24m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBXO40 CEBPE HLA-DQA1 MMP25 FECH FOXF1	9.11e-06	143	150	6	52832321cc848739ff6483f467d57c50c8b7395c
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SYNM ACTA2 ACTC1 EHD2 SRL MYOCD	1.29e-05	152	150	6	bd1f36b436d8ab7dd8420f595b97d851eab31a38
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SYNM ACTA2 ACTC1 EHD2 SRL MYOCD	1.29e-05	152	150	6	ee329249a034a969a16b26a224aa04249d67382d
ToppCell	5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-cDC1\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	OFD1 HLA-DQA1 MAP3K8 BCL6 PIK3R6 PAK1	1.85e-05	162	150	6	448602d5ff8b5be9614c63540a4d0fe6bdaf23b4
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-BM_CD4_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ESPN WDR47 USHBP1 C4A TNS1 FOXF1	2.12e-05	166	150	6	aa2df07eff323ded751ced8938af08223d7f2029
ToppCell	NS-critical-d_0-4-Epithelial-unknown_epithelial\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	NUDT19 ESPN BACH2 RPS6KB1 PNCK PDCL	2.12e-05	166	150	6	dd02bbe4af609c6348dc92417254f4740f2900a8
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ESPN WDR47 USHBP1 C4A TNS1 FOXF1	2.12e-05	166	150	6	695298a94d62b8adab083900003ec636fbaae5d9
ToppCell	VE-Treg-exh_CD4\|VE / Condition, Cell_class and T cell subcluster	MINK1 PELI3 WDR47 MMP25 SLC4A5 PPP6R3	2.20e-05	167	150	6	1036ac1ef9440612500137af9d1929672b077e4d
ToppCell	droplet-Spleen-SPLEEN-30m-Myeloid-macrophage_dendritic_cell_progenitor\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAM12 NRXN2 SLC27A1 SRL PNCK KHK	2.59e-05	172	150	6	30916a902c151907745756d14327e24adc34afef
ToppCell	5'-Adult-LymphNode-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SYNM ACTA2 EHD2 SRL MYOCD TNS1	2.86e-05	175	150	6	294a70786260c9a2b1ba16c88819d786698609e7
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAM12 C1QL1 NRXN2 PTPRZ1 NCAN CCDC171	2.86e-05	175	150	6	d67c77eee979ad029e7545f383326f0ff77c6e5f
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAM12 C1QL1 NRXN2 PTPRZ1 NCAN CCDC171	2.86e-05	175	150	6	1d1cdbf3221b03e24eae38afd57cbd6736b37a53
ToppCell	5'-Adult-LymphNode-Mesenchymal-Pericytes\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SYNM ACTA2 EHD2 SRL MYOCD TNS1	2.86e-05	175	150	6	798f33bd340261c048b7b45c842b2ccd1ea1fb60
ToppCell	droplet-Marrow-BM-30m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HLA-DQA1 SLC51B SLC15A4 SLC27A1 PNCK TNS1	2.95e-05	176	150	6	d4075796c38b775fe721abb47426e662a0d415e3
ToppCell	COPD-Stromal-SMC\|COPD / Disease state, Lineage and Cell class	SYNM ACTA2 ACTC1 SRL MYOCD TNS1	3.25e-05	179	150	6	5c705627bd13a5b2c7b0062fb3d94e4eb1589327
ToppCell	droplet-Spleen-nan-24m-Myeloid-macrophage_dendritic_cell_progenitor\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAM171A1 NRXN2 SLC27A1 PNCK KHK TNS1	3.25e-05	179	150	6	d50d29f26d5a2cd8c4cd4e1244e1bb8de072d159
ToppCell	tumor_Lymph_Node_/_Brain-Fibroblasts-Smooth_muscle_cells\|Fibroblasts / Location, Cell class and cell subclass	MBTPS1 SYNM ACTA2 SHMT1 ACTC1 WDR47	3.25e-05	179	150	6	83506e00fe99b6450efd2f13f716926a0a4b03cd
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAM12 C1QL1 NRXN2 PTPRZ1 NCAN C4B	3.45e-05	181	150	6	1037051eb82313c13346617b33f3c4c648181c4d
ToppCell	Pericytes-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	SYNM ACTA2 C1QL1 SRL MYOCD LTK	3.67e-05	183	150	6	4617b18da8d699a44e4c47980197b1e7eb951470
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SYNM ACTA2 MYOCD PNCK TNS1 FOXF1	3.67e-05	183	150	6	61a73de857f4ae02dcba3af348f436f602b28ff2
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HLA-DQA1 MAP3K8 BCL6 PIK3R6 PAK1 HSH2D	3.79e-05	184	150	6	4f4aeef3b821a003e857fe4a195124d44b2d7479
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FBXO40 CENPF ACTA2 ACTC1 C1QL1 PTPRZ1	3.79e-05	184	150	6	d1e0e3b0eed2db8a5b7e3d6f81294667e4ba64e5
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic-mast_cell\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ADAM12 PIK3R6 PAK1 ALDH1A1 TNS1 VAT1	3.90e-05	185	150	6	3fafb1d36c5f98a29d20a5ce5192c83d6f603514
ToppCell	Pericytes-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	BACH2 ACTA2 ACTC1 SRL MYOCD FOXF1	4.14e-05	187	150	6	35f25780d113f60bf4c13749013c09612ee4ff41
ToppCell	IPF-Stromal-SMC\|World / Disease state, Lineage and Cell class	SYNM ACTA2 ACTC1 EHD2 MYOCD C4B	4.27e-05	188	150	6	b66264e8f8d536ed2beec31e6746c687718f239b
ToppCell	droplet-Lung-nan-18m-Mesenchymal-Airway_Smooth_Muscle\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBXO40 ACTA2 ACTC1 PTPRZ1 PNCK IHH	4.27e-05	188	150	6	61f010c165826b434ca3d27553d4c9e13d2c0c51
ToppCell	droplet-Lung-nan-18m-Mesenchymal-bronchial_smooth_muscle_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBXO40 ACTA2 ACTC1 PTPRZ1 PNCK IHH	4.27e-05	188	150	6	7553ef7de3575af4cf34704b405b551c1af8eb83
ToppCell	COPD-Stromal-SMC\|Stromal / Disease state, Lineage and Cell class	SYNM ACTA2 ACTC1 SORT1 SRL MYOCD	4.27e-05	188	150	6	9ffef4b01d0ddd6913c9ed6be79aeaaabd5e41ed
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAM12 C1QL1 KANK1 NRXN2 PTPRZ1 NCAN	4.27e-05	188	150	6	006db2c2c44971ca9241c582bc89f258c785f5ed
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAM12 C1QL1 KANK1 NRXN2 PTPRZ1 NCAN	4.27e-05	188	150	6	d0e6fb4a3b3d79d3512b5500062ea285495ae526
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SYNM ACTA2 ACTC1 MDH1 MYOCD PNCK	4.53e-05	190	150	6	e102622f05c7f3e1bd8b224ea159d57033793ee0
ToppCell	COVID-19-Heart\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FBXO40 SYNM ACTA1 ACTC1 SRL MYOCD	4.53e-05	190	150	6	918ad5037881212008f9f69d5df5da91fd01422c
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	FBXO40 FN3K DGLUCY KANK1 SRL MYOCD	4.53e-05	190	150	6	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	COVID-19-kidney-vSMC/Pericyte\|kidney / Disease (COVID-19 only), tissue and cell type	SYNM ACTA2 ACTC1 BCL6 SRL MYOCD	4.66e-05	191	150	6	fad8eaa536001b911d05ae2b12150c2398cc6f88
ToppCell	3'-GW_trimst-1-LargeIntestine-Epithelial-mature_enterocytic-Colonocyte\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ESPN MUC5B SLC51B LCN15 PNCK IHH	4.80e-05	192	150	6	9f7e0d610741288d0779bd7c02852c791431e4ea
ToppCell	P28-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ACTA2 ACTC1 KANK1 PTPRZ1 MYOCD PNCK	4.80e-05	192	150	6	87c7780cf72f4c204f2a5f6655309d47a23c08ae
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SYNM ACTA2 ACTC1 MDH1 MYOCD PNCK	4.94e-05	193	150	6	173f1d83133f5ffa88e2a75d28835ad7acd2aa90
ToppCell	368C-Fibroblasts-Fibroblast-K_(Pericytes)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	SYNM ACTA1 ACTA2 ACTC1 SORT1 MYOCD	4.94e-05	193	150	6	5260ac95a15cc43a19909badad0c7e3854da920d
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SYNM ACTA2 ACTC1 MDH1 MYOCD PNCK	4.94e-05	193	150	6	b1893193766ae41bf2ab6ed4083285c9c814e608
ToppCell	368C-Fibroblasts-Fibroblast-K_(Pericytes)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	SYNM ACTA1 ACTA2 ACTC1 SORT1 MYOCD	4.94e-05	193	150	6	5ec917931b438dd0e7fb03eb6af459d3ef6b84ba
ToppCell	10x5'-blood-Lymphocytic_NK-NK_CD16\|blood / Manually curated celltypes from each tissue	MAP3K8 APMAP MXD4 SLC15A4 HSH2D CHST2	5.08e-05	194	150	6	c34a32f1cfe3e597cb0f91ba5bdd3e114e9f3d2e
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ACTA2 ACTC1 MDH1 MYOCD ALDH1A1 FOXF1	5.08e-05	194	150	6	12a2c60303607b8b5812405ad216d0612c56c64b
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal-myocytic\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ACTA2 ACTC1 MDH1 MYOCD ALDH1A1 FOXF1	5.08e-05	194	150	6	15060cc25baf49dd04d9c20499e28718610ef754
ToppCell	10x5'-Liver-Lymphocytic_NK\|Liver / Manually curated celltypes from each tissue	MAP3K8 APMAP LDB2 SLC15A4 HSH2D CHST2	5.08e-05	194	150	6	0b78f4ed84bbaca9f72f005c16c7492bb01d4328
ToppCell	10x5'-blood-Lymphocytic_NK\|blood / Manually curated celltypes from each tissue	MAP3K8 APMAP MXD4 SLC15A4 HSH2D CHST2	5.23e-05	195	150	6	c1db871e8e8e8b8d6a5798bc43eaf54e102b75eb
ToppCell	3'-Pediatric_IBD-SmallIntestine-Mesenchymal-myocytic\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ACTA2 ACTC1 EHD2 MYOCD TNS1 FOXF1	5.23e-05	195	150	6	44f67437ea65d530133a0240b17f9860d9cc0e99
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ACTA2 ACTC1 KANK1 PTPRZ1 MYOCD C4B	5.23e-05	195	150	6	43d372373367b71243c6ea958aedccde4478618f
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_NK\|lymph-node_spleen / Manually curated celltypes from each tissue	MAP3K8 APMAP LDB2 SLC15A4 HSH2D CHST2	5.38e-05	196	150	6	93ff94fc2b2ca8bd6a6492cbc0b402daf5d63ea2
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SYNM ACTA2 EHD2 SRL MYOCD TNS1	5.38e-05	196	150	6	ce6f7ddb8104471dc90347f427486379914d63b4
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-K_(Pericytes)\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	SYNM ACTA1 ACTA2 ACTC1 SORT1 MYOCD	5.38e-05	196	150	6	541b1fcf509e362f6f48720046cb5378aaf7c591
ToppCell	(0)_Myeloid-(010)_cDC\|(0)_Myeloid / immune cells in Peripheral Blood (logTPM normalization)	OFD1 CENPF HLA-DQA1 BACH2 PRPF19 SDS	5.38e-05	196	150	6	ea8cf29a9d4d177d092b0568fd4601cd7f906884
ToppCell	367C-Fibroblasts-Fibroblast-K_(Pericytes)\|367C / Donor, Lineage, Cell class and subclass (all cells)	SYNM ACTA2 ACTC1 EHD2 SRL MYOCD	5.38e-05	196	150	6	c390ef0adff35111989a30dff86b7c5db1a89873
ToppCell	367C-Fibroblasts-Fibroblast-K_(Pericytes)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	SYNM ACTA2 ACTC1 EHD2 SRL MYOCD	5.38e-05	196	150	6	2f76f050083483f0880639e6c34ff349caac3503
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-myocytic\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ACTA2 ACTC1 EHD2 MYOCD TNS1 FOXF1	5.38e-05	196	150	6	20dc9b25ecc23b6e6e52bbab8b5a404f3245ca37
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-Pericytes\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SYNM ACTA2 EHD2 SRL MYOCD TNS1	5.38e-05	196	150	6	6d7179decea512dd49bb2d5f6a4f5989349d52a9
ToppCell	BAL-Severe-Myeloid-TRAM-TRAM2\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	HLA-DQA1 PELI3 MDH1 SORT1 ALDH1A1 VAT1	5.53e-05	197	150	6	d8ef5cb88dd66e112cb94217b9ad5cd70164f1d0
ToppCell	BAL-Severe-Myeloid-TRAM-TRAM2\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DQA1 PELI3 MDH1 SORT1 ALDH1A1 VAT1	5.53e-05	197	150	6	33f2fe101ae5744eea3915add37e60aa398bb97f
ToppCell	BAL-Severe-Myeloid-TRAM-TRAM2-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DQA1 PELI3 MDH1 SORT1 ALDH1A1 VAT1	5.53e-05	197	150	6	5e9a3932ae5147a3d73dc70f1545926a692930ed
ToppCell	Fibroblast\|World / shred by cell class for bronchial biopsy	SYNM ACTBL2 ACTA2 ACTC1 MYOCD FOXF1	5.53e-05	197	150	6	8bf9846228b6b6721b10375fe54a2fb389ff64a6
ToppCell	Severe_COVID-19-Myeloid-TRAM2\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	HLA-DQA1 PELI3 MDH1 SORT1 ALDH1A1 VAT1	5.53e-05	197	150	6	8a126cfe1529f3d75a806aa492743314a8a43ef9
ToppCell	BAL-Severe-Myeloid-TRAM-TRAM2-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HLA-DQA1 PELI3 MDH1 SORT1 ALDH1A1 VAT1	5.53e-05	197	150	6	9262785807faeb32417fad7ef202405053e453e2
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SYNM ACTA2 CDH23 C4A MYOCD TNS1	5.53e-05	197	150	6	ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7
ToppCell	Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	SYNM ACTA1 ACTA2 ACTC1 MYOCD TNS1	5.53e-05	197	150	6	470e23dee4ca35e1fd021b7cdd58fcbc90639837
ToppCell	Transplant_Alveoli_and_parenchyma-Mesenchymal-Smooth_muscle\|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X	SYNM ACTA2 SORT1 SRL MYOCD TNS1	5.69e-05	198	150	6	89986c7756541df364df516329d10775ba0e78a4
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SYNM ACTA2 ACTC1 EHD2 SRL MYOCD	5.69e-05	198	150	6	77288df94286382170a266474ab85960519e8449
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SYNM ACTA2 ACTC1 EHD2 SRL MYOCD	5.69e-05	198	150	6	2ee195f20a4f91fa1dcad9eaf96d6086e3b0fb4a
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SYNM ACTA2 MYOCD PNCK TNS1 FOXF1	5.69e-05	198	150	6	c12e7511628db819a52959bb68580e27c00c2e41
ToppCell	normal_Lymph_Node-T/NK_cells-NK\|T/NK_cells / Location, Cell class and cell subclass	MAP3K8 APMAP LDB2 SLC15A4 HSH2D CHST2	5.69e-05	198	150	6	75e94298bf03d755fef46df685437d0d29fdbca9
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SYNM ACTA2 MYOCD PNCK TNS1 FOXF1	5.69e-05	198	150	6	22e766df1276c5b14aa0d83f434f47140ebb98ea
ToppCell	Tracheal-10x5prime-Stromal-Myofibroblastic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SYNM ACTA2 ACTC1 SRL MYOCD TNS1	5.85e-05	199	150	6	0a145172787f40d0fdaf21188d539ffaf7ece3e4
ToppCell	Tracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	SYNM ACTA2 ACTC1 MYOCD PNCK TNS1	5.85e-05	199	150	6	056a28c36cd58dc695a5ae6f29b62135d6aad819
ToppCell	Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SYNM ACTA2 ACTC1 SRL MYOCD TNS1	5.85e-05	199	150	6	c2903b1a4b91e94bbdaa909bacefe901255cf248
ToppCell	Sepsis-ICU-SEP-Lymphocyte-T/NK-MAIT\|ICU-SEP / Disease, condition lineage and cell class	OFD1 SYNM MINK1 FAM171A1 KANK1 CCDC171	5.85e-05	199	150	6	2f10622319c6146dfed8cfe3844180c1e1d56e94
ToppCell	distal-3-Endothelial-Capillary_Aerocyte\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LDB2 USHBP1 LTK NOS2 FOXF1 VAT1	6.02e-05	200	150	6	e12598a097dd9c4cbf9bb85bfa3057722ef73ad5
Computational	CoA and fatty acid metabolism.	SHMT1 MDH1 ALDH1A1 ALDH9A1	2.18e-05	19	97	4	MODULE_305
Drug	microcystin-LR	HDAC4 ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2 MDH1 PPP5C PAK1 NOS2	1.18e-08	129	147	10	CID000445433
Drug	Nsc687160	ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2	8.39e-08	18	147	5	CID005459290
Drug	tolytoxin	ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2	1.13e-07	19	147	5	CID006440827
Drug	NSC312786	ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2	1.96e-07	21	147	5	CID000329495
Drug	AC1L8NVR	ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2	1.96e-07	21	147	5	CID000384633
Drug	L-Carnosine	ACTA1 ACTA2 ACTC1 ACTRT2 FN3K SLC15A4 CNDP1	4.62e-07	73	147	7	CID000009369
Drug	dihydrosphingosine	MBTPS1 MAT1A ACTBL2 ACTA1 ACTA2 NUCB1 ACTC1 ACTRT2 AGXT	4.65e-07	146	147	9	CID000003126
Drug	AC1L9EF8	ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2 TGM1 SDS	7.96e-07	79	147	7	CID000443315
Drug	azaspiracid	ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2	1.31e-06	30	147	5	CID006451158
Drug	3-methylhistidine	ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2 CNDP1	1.46e-06	55	147	6	CID000064969
Drug	AC1L1HS4	ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2	1.83e-06	32	147	5	CID000004267
Drug	dihydrocytochalasin B	ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2 TGM1	2.01e-06	58	147	6	CID000003064
Drug	NSC613009	ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2 PAK1 NOS2 SLC4A5	2.08e-06	130	147	8	CID000003800
Drug	acetaldehyde	OFD1 FNTB ACTBL2 ACTA1 ACTA2 SHMT1 ACTC1 ACTRT2 PPP5C ALDH1A1 ALDH9A1 SDS	2.11e-06	338	147	12	CID000000177
Drug	mDia	MBTPS1 ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2 SLC4A5	2.41e-06	93	147	7	CID000128346
Drug	N,N'-p-phenylenedimaleimide	ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2	2.51e-06	34	147	5	CID000076765
Drug	1,N6-ethenoadenosine 5'-diphosphate	ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2	2.51e-06	34	147	5	CID000001312
Drug	AC1NRBPQ	ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2 SUPT7L TNS1 CNDP1	3.09e-06	137	147	8	CID005288569
Drug	DE gel	ACTBL2 ACTA1 ACTA2 ACTC1 POU3F4 ACTRT2 BSN NOS2	4.25e-06	143	147	8	CID000008146
Drug	ML-9	MBTPS1 RPS6KB1 ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2 PAK1	5.22e-06	147	147	8	CID000004217
Drug	Chlorphensin carbamate [886-74-8]; Up 200; 16.2uM; MCF7; HT_HG-U133A	CEBPE MAP3K8 PCDHGA1 POU3F4 C1QL1 MMP25 TJAP1 CHST2 TNS1	5.57e-06	197	147	9	2279_UP
Drug	ammonia	MAT1A APMAP ACTBL2 ACTA1 ACTA2 SHMT1 ACTC1 ACTRT2 MDH1 FN3K TGM1 AGXT NOS2 SDS	5.75e-06	509	147	14	CID000000222
Drug	m2-19	ACTA1 ACTA2 ACTC1 ACTRT2	6.00e-06	19	147	4	CID000079129
Drug	epsilon-ATP	ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2	6.51e-06	41	147	5	CID000162262
Drug	9-beta-D-arabinofuranosylguanine	MBTPS1 PDE6H POLE RPS6KB1 ACTBL2 ACTA1 ACTA2 NUCB1 ACTC1 ACTRT2 SORT1 TGM1 SUPT7L PAK1 PAK2 C4A GNAI3 NOS2	8.74e-06	843	147	18	CID000000765
Drug	AC1L8FNU	ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2	9.29e-06	44	147	5	CID000425429
Drug	SIRIUS	SYNM ACTA1 ACTA2 ACTC1 ACTRT2 LTK	1.06e-05	77	147	6	CID000091750
Drug	NpCaM	ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2	1.43e-05	48	147	5	CID000122259
Drug	AC1Q6LQU	ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2	1.43e-05	48	147	5	CID000072380
Drug	plakin	ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2 SNTB2	1.53e-05	82	147	6	CID000018752
Drug	Formyl	ACTBL2 ACTA1 ACTA2 SHMT1 ACTC1 ACTRT2 HSH2D NOS2 CNDP1	2.52e-05	238	147	9	CID000123370
Drug	aldonates	SHMT1 HUWE1 AGXT KHK ALDH9A1 SDS	2.61e-05	90	147	6	CID000000752
Drug	methyl ethyl ketone	MBTPS1 MAP3K8 BACH2 RPS6KB1 ACTA1 ACTA2 ACTC1 ACTRT2 ADAM12 PPP5C PAK1 PAK2 MYOCD NOS2	2.82e-05	587	147	14	CID000006569
Drug	CID5288653	ACTA1 ACTA2 ACTC1 ACTRT2	3.03e-05	28	147	4	CID005288653
Drug	arabinosyladenine	PDE6H MAT1A ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2 AGPS MDH1 POLR3B AGXT C4A BSN NOS2 CPSF3 SDS	3.49e-05	762	147	16	CID000000191
Drug	Cyanocobalamin [68-19-9]; Down 200; 3uM; MCF7; HT_HG-U133A	ING1 MAP3K8 MINK1 C1QL1 TJAP1 POLL PRR14L PDCL	3.63e-05	192	147	8	4395_DN
Drug	tert-butylbenzene	MAT1A C4A	4.14e-05	2	147	2	CID000007366
Drug	NSC3096	ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2 SLC4A5	4.22e-05	98	147	6	CID000002832
Drug	Bemegride [64-65-3]; Down 200; 25.8uM; PC3; HT_HG-U133A	RPH3AL KIAA0232 MINK1 ADAM12 C1QL1 UBA6 TJAP1 TNS1	4.51e-05	198	147	8	6668_DN
Drug	Nifedipine [21829-25-4]; Down 200; 11.6uM; PC3; HT_HG-U133A	RPH3AL CENPF MINK1 ADAM12 MXD4 TRIM23 SUPT7L TNS1	4.51e-05	198	147	8	7303_DN
Drug	monomethyl phthalate	ATMIN CEBPE HDAC4 ATR CENPF RPS6KB1 ACTA1 GLOD4 ADNP MXD4 SORT1 WDHD1 UBA6 POLL ALDH1A1 CHST2 FOXF1 PPP6R3	4.69e-05	957	147	18	ctd:C517284
Drug	PI(3,4,5)P3	RPS6KB1 ACTA1 ACTA2 ACTC1 ACTRT2 SUPT7L TNS1	5.07e-05	148	147	7	CID000643963
Drug	oryzalin	ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2	5.45e-05	63	147	5	CID000029393
Drug	beryllium fluoride	ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2 AGPS	5.59e-05	103	147	6	CID000024589
Drug	carbodiimide	MAT1A ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2 ALDH9A1	5.76e-05	151	147	7	CID000009864
Drug	nitroglycerin	ACTBL2 ACTA1 ACTA2 ACTC1 BIRC2 ACTRT2 ALDH1A1 NOS2	5.96e-05	206	147	8	CID000004510
Drug	5-IAF	ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2	6.82e-05	66	147	5	CID000123822
Drug	NSC406942	FNTB SYNM APMAP ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2 MDH1 FECH KHK BSN NOS2	7.92e-05	565	147	13	CID000001115
Drug	AC1NSKFN	ACTA1 ACTA2 ACTC1 ACTRT2	8.37e-05	36	147	4	CID005311324
Drug	succinic semialdehyde	SHMT1 MDH1 ALDH1A1 ALDH9A1 CNDP1	8.45e-05	69	147	5	CID000001112
Drug	AC1L1ERT	ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2	8.45e-05	69	147	5	CID000002920
Drug	caged ATP	ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2	9.05e-05	70	147	5	CID000123806
Drug	AC1MNW2N	ACTA1 ACTA2 ACTC1 ACTRT2 MYOCD	9.05e-05	70	147	5	CID003359490
Drug	kabiramide C	ACTBL2 ACTC1 C4A	9.11e-05	14	147	3	CID005288658
Drug	HU-211	ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2 NOS2	9.83e-05	114	147	6	CID000107778
Drug	auxin	FNTB ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2 AGPS ALDH9A1	1.07e-04	224	147	8	CID000000801
Drug	AC1L1GZB	ACTA1 ACTA2 ACTC1 ACTRT2 PAK2 C4A CNDP1	1.08e-04	167	147	7	CID000003908
Drug	C3H2N2O3S	ACTA1 ACTA2 ACTC1 ACTRT2 PAK1	1.18e-04	74	147	5	CID000448652
Drug	Co-protoporphyrin IX	ACTA1 ACTA2 ACTC1 ACTRT2 FECH NOS2	1.19e-04	118	147	6	CID000004972
Drug	Pb m	ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2 CHST2	1.19e-04	118	147	6	CID006327255
Drug	2-aminothiophenol	C4A C4B	1.24e-04	3	147	2	ctd:C005464
Drug	AC1LD8HW	ACTA1 ACTA2 ACTC1 ACTRT2 PRPF19	1.26e-04	75	147	5	CID000644061
Drug	C2-ceramide	MBTPS1 CEBPE ACTBL2 ACTA1 ACTA2 ACTC1 ACTRT2 ADNP NOS2	1.28e-04	294	147	9	CID000002505
Drug	5'-N-ethylcarboxamidoadenosine	POLE ACTA1 ACTA2 ACTC1 ACTRT2 BSN NOS2	1.40e-04	174	147	7	CID000104795
Drug	sulfobetaine	MAT1A SHMT1 SDS	1.68e-04	17	147	3	CID000160765
Drug	NSC-614616	SHMT1 AGXT SDS	1.68e-04	17	147	3	CID000000690
Disease	patent ductus arteriosus (implicated_via_orthology)	ACTBL2 ACTA1 ACTA2 ACTC1 MYOCD	6.61e-10	10	145	5	DOID:13832 (implicated_via_orthology)
Disease	Moyamoya disease (implicated_via_orthology)	ACTBL2 ACTA1 ACTA2 ACTC1	3.86e-08	8	145	4	DOID:13099 (implicated_via_orthology)
Disease	autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology)	ACTBL2 ACTA1 ACTA2 ACTC1	3.86e-08	8	145	4	DOID:0110550 (implicated_via_orthology)
Disease	Baraitser-Winter syndrome 1 (implicated_via_orthology)	ACTBL2 ACTA1 ACTA2 ACTC1	3.86e-08	8	145	4	DOID:0081112 (implicated_via_orthology)
Disease	thoracic aortic aneurysm (implicated_via_orthology)	ACTBL2 ACTA1 ACTA2 ACTC1	3.86e-08	8	145	4	DOID:14004 (implicated_via_orthology)
Disease	intestinal atresia (implicated_via_orthology)	ACTBL2 ACTA1 ACTA2 ACTC1	1.15e-07	10	145	4	DOID:10486 (implicated_via_orthology)
Disease	childhood trauma measurement, alcohol consumption measurement	PCDHGA11 PCDHGA7 PCDHGA6 PCDHGA1 MYOCD	2.68e-05	71	145	5	EFO_0007878, EFO_0007979
Disease	Pneumoconiosis	ATR CDH23 PTPRZ1	4.07e-05	14	145	3	C0032273
Disease	Bagassosis	ATR CDH23 PTPRZ1	4.07e-05	14	145	3	C0004681
Disease	Proteinuria	NPHS1 HLA-DQA1 PAK1 PAK2	5.95e-05	43	145	4	C0033687
Disease	Stomach Neoplasms	ATR ING1 POLE ACTC1 BIRC2 XRCC3 URM1 PRPF19	1.16e-04	297	145	8	C0038356
Disease	Malignant neoplasm of stomach	ATR ING1 POLE ACTC1 BIRC2 XRCC3 URM1 PRPF19	1.24e-04	300	145	8	C0024623
Disease	Squamous cell carcinoma of oropharynx	ATR ING1	1.43e-04	4	145	2	C0280313
Disease	Sarcosine measurement	PCDHGA7 PCDHGA6 PCDHGA1	1.92e-04	23	145	3	EFO_0021668
Disease	matrilysin measurement	MMP25 CEP126	2.38e-04	5	145	2	EFO_0008227
Disease	mental development measurement	PCDHGA7 PCDHGA6 PCDHGA1	2.47e-04	25	145	3	EFO_0008230
Disease	glucocorticoid receptor gene expression measurement	KIAA0232 LDB2 SLC15A4	3.12e-04	27	145	3	EFO_0600079
Disease	Hyalinosis, Segmental Glomerular	NPHS1 ACTA2 NOS2	3.48e-04	28	145	3	C0086432
Disease	body mass index, vital capacity	HLA-DQA1 IHH	3.55e-04	6	145	2	EFO_0004312, EFO_0004340
Disease	rhegmatogenous retinal detachment	FAT3 LDB2	3.55e-04	6	145	2	EFO_0005240
Disease	Lupus Erythematosus, Systemic	HLA-DQA1 SLC15A4 C4A C4B	4.21e-04	71	145	4	C0024141
Disease	Liver diseases	ACTA2 SORT1 TGM1 NOS2	4.44e-04	72	145	4	C0023895
Disease	Liver Dysfunction	ACTA2 SORT1 TGM1 NOS2	4.44e-04	72	145	4	C0086565
Disease	tumor necrosis factor receptor superfamily member 6 measurement	HLA-DQA1 ACTA2	4.96e-04	7	145	2	EFO_0010610
Disease	helix rolling	FECH CCNYL2	6.59e-04	8	145	2	EFO_0007670
Disease	endometrial cancer (implicated_via_orthology)	ATR POLE	6.59e-04	8	145	2	DOID:1380 (implicated_via_orthology)
Disease	Focal glomerulosclerosis	NPHS1 ACTA2 NOS2	7.37e-04	36	145	3	C0017668
Disease	central nervous system non-hodgkin lymphoma	HLA-DQA1 BACH2	8.44e-04	9	145	2	MONDO_0044887
Disease	breast cancer (is_implicated_in)	HLA-DQA1 SHMT1 BIRC2 XRCC3 PAK1	8.94e-04	150	145	5	DOID:1612 (is_implicated_in)
Disease	Graves' disease (is_implicated_in)	HLA-DQA1 C4A C4B	9.33e-04	39	145	3	DOID:12361 (is_implicated_in)
Disease	linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1] measurement	GATAD2A NCAN	1.05e-03	10	145	2	EFO_0800499
Disease	vascular endothelial function measurement	HDAC4 ADAM12 PTPRZ1 TRIM44	1.47e-03	99	145	4	EFO_0803369
Disease	selective IgA deficiency disease	HLA-DQA1 CDH23 FAM171A1	1.51e-03	46	145	3	EFO_1001929
Disease	rac GTPase-activating protein 1 measurement	HLA-DQA1 C4B	1.53e-03	12	145	2	EFO_0801985
Disease	Liver Cirrhosis, Experimental	RPH3AL MAP3K8 APMAP ACTA2 MDH1 KANK1 L3HYPDH ALDH1A1 NOS2 SDS CNDP1	1.59e-03	774	145	11	C0023893
Disease	Genetic chronic primary adrenal insufficiency	HLA-DQA1 BACH2	1.81e-03	13	145	2	Orphanet_101960
Disease	actinic keratosis	HLA-DQA1 HERC2	2.10e-03	14	145	2	EFO_0002496
Disease	C-C motif chemokine 19 measurement	HLA-DQA1 BSN	2.10e-03	14	145	2	EFO_0008047
Disease	cancer (implicated_via_orthology)	ING1 POLE KANK1 FECH LTK PIPSL	2.16e-03	268	145	6	DOID:162 (implicated_via_orthology)
Disease	Cholestasis	SORT1 SLC51B KANK1 NOS2	2.16e-03	110	145	4	C0008370
Disease	hyperinsulinism (biomarker_via_orthology)	RPS6KB1 SLC27A1	2.41e-03	15	145	2	DOID:2018 (biomarker_via_orthology)
Disease	level of triacylglycerol (56:6) in blood serum	GATAD2A NCAN	2.75e-03	16	145	2	OBA_2020007
Disease	keratinocyte carcinoma	HLA-DQA1 BACH2 KANK1 HERC2	2.78e-03	118	145	4	EFO_0010176
Disease	FEV/FEC ratio	HDAC4 HLA-DQA1 KIAA0232 PCDHGA1 BACH2 CDH23 ADAM12 LDB2 SLC51B KANK1 CHST2 HERC1 CCDC171 TNS1	2.99e-03	1228	145	14	EFO_0004713
Disease	Benign neoplasm of stomach	ATR POLE	3.11e-03	17	145	2	C0153943
Disease	Neoplasm of uncertain or unknown behavior of stomach	ATR POLE	3.11e-03	17	145	2	C0496905
Disease	Carcinoma in situ of stomach	ATR POLE	3.11e-03	17	145	2	C0154060
Disease	MHPG measurement, 5-HIAA measurement	ADAM12 CCDC171	3.11e-03	17	145	2	EFO_0005132, EFO_0005133
Disease	Hereditary Diffuse Gastric Cancer	ING1 ACTC1 BIRC2 XRCC3 URM1 PRPF19	3.35e-03	293	145	6	C1708349
Disease	ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis	BACH2 RPS6KB1 ACTA2 PPP5C BSN NOS2	3.46e-03	295	145	6	EFO_0000384, EFO_0000676, EFO_0000729, EFO_0003898, EFO_0004268
Disease	Febrile seizure (within the age range of 3 months to 6 years)	HERC1 BSN	3.48e-03	18	145	2	HP_0002373
Disease	Malignant neoplasm of endometrium	ATR POLE	3.48e-03	18	145	2	C0007103
Disease	Carcinoma in situ of endometrium	ATR POLE	3.48e-03	18	145	2	C0346191
Disease	Chronic myeloproliferative disorder	ATR CENPF	3.88e-03	19	145	2	C1292778
Disease	squamous cell carcinoma	HLA-DQA1 BACH2 HERC2	4.42e-03	67	145	3	EFO_0000707
Disease	Lymphoma, Diffuse	SHMT1 BCL6	4.74e-03	21	145	2	C3714542
Disease	Stomach Carcinoma	ATR POLE	4.74e-03	21	145	2	C0699791
Disease	Low Grade Lymphoma (neoplasm)	SHMT1 BCL6	4.74e-03	21	145	2	C0079747
Disease	Lymphoma, Intermediate-Grade	SHMT1 BCL6	4.74e-03	21	145	2	C0079741
Disease	High Grade Lymphoma (neoplasm)	SHMT1 BCL6	4.74e-03	21	145	2	C0079740
Disease	Diffuse Mixed-Cell Lymphoma	SHMT1 BCL6	4.74e-03	21	145	2	C0079757
Disease	Lymphoma, Undifferentiated	SHMT1 BCL6	4.74e-03	21	145	2	C0024306
Disease	vitiligo (is_implicated_in)	HLA-DQA1 C4A	4.74e-03	21	145	2	DOID:12306 (is_implicated_in)
Disease	Reticulosarcoma	SHMT1 BCL6	4.74e-03	21	145	2	C0024302
Disease	Lymphoma, Mixed-Cell	SHMT1 BCL6	4.74e-03	21	145	2	C0024304
Disease	renal cell carcinoma (is_implicated_in)	PAK1 C4A C4B	4.81e-03	69	145	3	DOID:4450 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
PSHSGPMEFEGTSEG	USHBP1	141	Q8N6Y0
GHGGDTLDAEPMLAG	AMER3	661	Q8N944
GHAFSEMQECGAGTP	CEP295NL	376	Q96MC4
TDGVAEPMHGSLAGV	ADNP	1081	Q9H2P0
FLATEHQEPGLMGDG	BACH2	556	Q9BYV9
SMAGEHIQLPGGSFG	ALDH9A1	126	P49189
GPGELGDMCEHEASI	CEBPE	26	Q15744
MGLDGATYDLEGHPQ	C4B	1686	P0C0L5
HFDDIGPSVVMASPG	CPSF3	316	Q9UKF6
PSFIGMESAGIHETT	ACTA1	266	P68133
SGEFGPRHMVSSIVG	ACTRT2	26	Q8TDY3
GIVMDSGDGVTHIVP	ACTBL2	151	Q562R1
HLETFAMEGLKGGPE	CCDC171	1181	Q6TFL3
MHGDTEGTVPGNALV	EHD2	101	Q9NZN4
MLELDSSGHLDGPGG	GSDMC	361	Q9BYG8
PSFIGMESAGIHETT	ACTA2	266	P62736
MDVSSEHTKDPGGEG	CCDC96	1	Q2M329
VLVSSGGPEGHYEML	C1QL1	11	O75973
GPTAGAAISSHMDID	ALDH1A1	226	P00352
GGIVMDHSDNPLGAA	ADAM12	331	O43184
GPESIAHIGDVMFTG	APMAP	101	Q9HDC9
PGVEAFHVDMDSGLV	CDH23	2551	Q9H251
TVMSPCGGEDIVADH	HLA-DQA1	16	P01909
MHTGEPLFSGSNEVD	DYRK1B	306	Q9Y463
QGPGVTHIVVDEGMD	POLL	76	Q9UGP5
FAVQSHGVDMDGPFG	IGDCC4	821	Q8TDY8
HGVDMDGPFGSVVER	IGDCC4	826	Q8TDY8
VDFPTSGVAGGDMET	MUC5B	1796	Q9HC84
GLANVPTSHFVGMDG	PCDHGA7	731	Q9Y5G6
MFLGTGEPALDTGDD	IQCE	1	Q6IPM2
GGLSPAGDMSHVDAA	OFD1	841	O75665
GGLAGMPTSHFVGVD	PCDHGA11	731	Q9Y5H2
AASEPVAEGMDGGPH	ZFYVE28	536	Q9HCC9
VAEGMDGGPHKLSTG	ZFYVE28	541	Q9HCC9
SHLGASQLTPMGEGD	NOS2	646	P35228
GLVGDGPVDMRTSHS	GATAD2A	76	Q86YP4
MESGLTFHEVDSPQG	MMP25	151	Q9NPA2
GFTGEDEDMAFPGHL	NPHS1	1161	O60500
GLASMPGSHFVGVEG	PCDHGA6	731	Q9Y5G7
GVHLEMMSPGGEGDL	FAM171A1	396	Q5VUB5
SMEAAGIPVSFGGHR	HDAC4	611	P56524
IEGMEFGPGELDSVG	MXD4	161	Q14582
GAGSVTPERMEGNHL	MBTPS1	891	Q14703
AGSAEEGVMTPELAG	GNAI3	111	P08754
MPGAHVFSGGVLDAA	NUDT19	56	A8MXV4
TMVGFGPEDDHFVAE	GLOD4	71	Q9HC38
GRLGHGSSEDEAIPM	HERC2	581	O95714
HGGGDPTAATDMGAL	ESPN	126	B1AK53
FVESAESDHMAIPGG	MCM3AP	366	O60318
TGVLHMASFGEGEQE	HERC1	1856	Q15751
VVGEPTLMGGEFGDE	LDB2	301	O43679
THAAFIAMAGPEGLG	BSN	2506	Q9UPA5
AGISEMFEGHQGPIT	DYNC1I2	466	Q13409
MSHQEGSTDGLPDLG	DCAF8L2	1	P0C7V8
PGEVTFVAGEGLHMH	CCNYL2	51	Q5T2Q4
TPEGEFVSMGVISDG	MDH1	261	P40925
ETVHLFMEAGEGGSV	MAP3K8	201	P41279
VEEHAAMDGSEGVPG	LTK	186	P29376
AAGTFIDGHFVEMPA	KIAA0232	461	Q92628
MPDDGGTAHLSVVAE	GGTLC1	31	Q9BX51
FGGKFCSEEEHPMEG	NRXN2	236	Q9P2S2
SELAEAFGEPHSQMG	KANK1	846	Q14678
NESMDHGGVGPYELG	RPS6KB1	51	P23443
GVFMFTSESVGEGHP	MAT1A	16	Q00266
TEEGGLHVHMEFPGA	LCN15	66	Q6UWW0
SEPLELMVSGHSGGS	LILRA6	411	Q6PI73
EAEGAVGALPGMITF	POLE	2036	Q07864
GGVDFHMKAVPGTEV	NOL8	121	Q76FK4
DGPMIVHDEHGGVTA	PTPRZ1	2216	P23471
FGDTGEGWETVEMHP	NUCB1	326	Q02818
MGGKVPVSEGLEHSD	HUWE1	1176	Q7Z6Z7
DDGTFMIPGEKVAHT	HSH2D	86	Q96JZ2
EEPHFDGIMDGFSGK	MYOCD	831	Q8IZQ8
QPGFTVSGMLEHGGL	POU3F4	136	P49335
GGTMETDDHMGGIPA	PIPSL	321	A2A3N6
IPEGEGASEQGMARH	PNCK	316	Q6P2M8
AQFHPDGLIFGTGTM	PRPF19	356	Q9UMS4
HVGFDAVTGEFTGMP	PAK1	86	Q13153
VGFDAVTGEFTGMPE	PAK2	86	Q13177
FHEGSAEDGPRVVFM	ASPHD2	331	Q6ICH7
AAMHEPDGVAGVSAI	ATR	1681	Q13535
GVDQGSATGAVHLMP	ATMIN	331	O43313
VMSGIHPAEDTEGTE	CENPF	2961	P49454
IHPEFCDEMDAGGLG	CHAMP1	36	Q96JM3
ENVTTLGGSGADHMP	CEP126	696	Q9P2H0
MEDDFPGGVIGKIHA	FAT3	3561	Q8TDW7
HTAGPTFPEEMGETQ	BCL6	491	P41182
ISSGHNMVEGEGAPK	FBXO40	251	Q9UH90
QPDGSFLMHVGGEVD	FNTB	186	P49356
GSMAPGHVADFLVAD	KHK	61	P50053
LGMTVEGPEGSEREH	FAM102A	271	Q5T9C2
MGGPETLGDVHDFLL	FECH	76	P22830
GIVGMEVDGLPFHNT	DGLUCY	586	Q7Z3D6
GDVPVIAMETFGAHS	SDS	186	P20132
MSHGGPFTEEKVEDV	SLC15A4	301	Q8N697
MGLDGATYDLEGHPQ	C4A	1686	P0C0L4
LEEGSFHPLGMSGAG	IHH	396	Q14623
GCPGMATFREDTGVH	PRR14L	1771	Q5THK1
MEHSEGAPGDPAGTV	SLC51B	1	Q86UW2
HIYEDGIPGTEAMNG	PDCL	186	Q13371
GEHSTAGEMGPLLGA	NAP1L6P	6	A6NFF2
GLASMPGSHFVGVDG	PCDHGA1	731	Q9Y5H4
DSHGEEGEPSSIMNV	MINK1	331	Q8N4C8
ESGGSVEAPRMGFTH	RPH3AL	241	Q9UNE2
LDLPDGGHLTHGFMT	SHMT1	141	P34896
IMEELLGSHPGDTGE	NUTM2F	401	A1L443
IMEELLGSHPGDTGE	NUTM2G	386	Q5VZR2
TGAGGVMEPHAVYSG	FOXF1	251	Q12946
MSEGDSVGESVHGKP	RER1	1	O15258
VFMHVDEPGDTGFGT	SORT1	361	Q99523
DHFDIEIMGGLGPST	AGXT	341	P21549
MASGVGAAFEELPHD	TRIM44	1	Q96DX7
MAAPLSVEVEFGGGA	URM1	1	Q9BTM9
VIGDSVHMEGLPGSS	SYNM	1291	O15061
TGETPIAVMGEFGDL	RFX3	646	P48380
VAEADEGGPSAITGM	ING1	16	Q9UK53
NGVLVMHPAGGFSED	PELI3	236	Q8N2H9
MHPAGGFSEDSAPGV	PELI3	241	Q8N2H9
MHGGLFSEDGVTLDD	PPP5C	351	P53041
PGTPMNAGAEEVHSD	NCAN	996	O14594
SGDGEMLPGVSRLHT	PIK3R6	401	Q5UE93
VIDLPGGGAAFVMEH	FN3K	76	Q9H479
APEMGEELLGSEGIH	RNF169	456	Q8NCN4
GHGVLGSDVFEEPMS	SUPT7L	356	O94864
PDSGHETMVGSGLSQ	KDF1	331	Q8NAX2
TTHNGGEMTEESEGP	SANBR	131	Q6NSI8
GTPVLSVVDMHTGGE	L3HYPDH	16	Q96EM0
IHFGPGESSSEDAVM	BIRC2	376	Q13490
PSFIGMESAGIHETT	ACTC1	266	P68032
TGPDIHHFIMGSEGT	AGPS	356	O00116
EGVGGPADYHALGAM	CHST2	381	Q9Y4C5
FGDDIPGMEGLGTDI	PDE6H	46	Q13956
HSGTFGGILHEPMAD	CNDP1	261	Q96KN2
FVHVDMSEGVPGDPA	TJAP1	261	Q5JTD0
MEGSEPVAAHQGEEA	UBA6	1	A0AVT1
NATGPDLEFSMHDGT	WDR47	696	O94967
GLFPAVGMHSLGEEV	SPRYD3	181	Q8NCJ5
QATSEDMHGFEAPGT	SPATA31A1	971	Q5TZJ5
GVEGKAGMAAVADPH	SLC27A1	546	Q6PCB7
SAHITEQLGMAPGGE	TRABD	156	Q9H4I3
VFSLAGPVVSMAGHG	WDHD1	566	O75717
GAEPTTSEFTVLMHG	SRL	126	Q86TD4
RDDGMEEVVGHTQGP	TNS1	346	Q9HBL0
SSGDDGEMPAMHEIG	SLC4A5	471	Q9BY07
GTEEHVMAAFGPSLE	POLR3B	256	Q9NW08
GLSEMQEGHFRPGID	ZNF264	131	O43296
GVDIVMDPLGGSDTA	VAT1	256	Q99536
QHPELGVGMTTEGFD	TTC30A	221	Q86WT1
VTMFLDGGGIAEEPS	UBXN7	46	O94888
RPHEDVFIMDTIGGG	STRN4	381	Q9NRL3
GDSHLGETIPMASRG	TGM1	801	P22735
GSMEGHGMDESLSPG	ZNF407	1946	Q9C0G0
HGMDESLSPGGAVIQ	ZNF407	1951	Q9C0G0
EDGIGMAHTEHVPGT	TRIM23	266	P36406
LDFGGPEGELTMDLH	SNTB2	501	Q13425
METTHGAPLDSVGSD	PPP6R3	691	Q5H9R7
EAMEEQGAAHGPLGF	XRCC3	261	O43542